ASPHALION´S SERVICES | REGISTRATION

The correct Marketing Authorization application for a medicinal product, together with product particularities and complex regulatory requirements are key steps to be considered to ensure timely product commercialization in strategically defined markets

The correct Marketing Authorization application for a medicinal product, together with product particularities and complex regulatory requirements are key steps to be considered to ensure timely product commercialization in strategically defined markets
September 12, 2022

Following evidence generation that indicates a product has the successful adequacy to treat a medical need, an appropriate regulatory registration procedure is required prior to commercialization.

This entails the definition, execution and formatting of registration eCTD dossiers and their management in terms of timing and content presentation, which are usually subject to standard formats and procedures requested by multiple authority bodies in each regulatory framework. This involves also a contextualization of such procedures regarding the type of product and the medical need to be covered.

Asphalion’s expertise aims at ensuring timely commercialization given the complexity of multiregional contexts, which requires a proper planning and management of document submission and product registration.

 

Have a look at all our solutions here:

https://www.asphalion.com/services/registration/

 

For further requests, you can send us an email at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

EVENTS | Asphalion present at Key events this year

At Asphalion, we’re excited to be part of key events, conferences, and summits throughout 2026—great opportunities to connect, exchange insights, and collaborate with leaders across healthcare and medical devices. 

EVENT | DIA Europe

DIA Europe 2026 will take place in Rotterdam from 24–26 March 2026. As Europe’s largest neutral conference in the life sciences sector, it will gather 1,500 professionals from over 50 countries for three days of exchange and collaboration. The programme features 10 dynamic tracks covering key areas such as Clinical Trials Innovation, AI & Real-World Evidence, Innovative Therapies, Medical Devices, and Pharmacovigilance, alongside 80+ sessions and contributions from 300+ experts, regulatory authorities, HTA bodies, payers, and patient organizations—offering a key platform to drive innovation and informed decision-making in healthcare.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting